Role of Progesterone in Nicotine Addiction: Evidence From Initiation to Relapse

Experimental and Clinical Psychopharmacology

Volumn 18, Issue 6, 2010, Pages 451-461

  Lynch, Wendy J ^a   Sofuoglu, Mehmet ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Nicotine; Progesterone; Sex differences; Tobacco; Translational research

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ELTANOLONE; PROGESTERONE;

AMENORRHEA; ARTICLE; COGNITION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG URINE LEVEL; HUMAN; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; NONHUMAN; OVARY INSUFFICIENCY; PREMENSTRUAL SYNDROME; RELAPSE; SEIZURE; TOBACCO DEPENDENCE; TRAUMATIC BRAIN INJURY; UTERUS BLEEDING;

ANIMALS; FEMALE; HUMANS; MALE; PREGNANCY; PROGESTERONE; PROGESTINS; RECURRENCE; SEX FACTORS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 78650975055     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0021265     Document Type: Article

References (118)

1. Allen A.M., Mooney M., Chakraborty R., Allen S.S. Circadian patterns of ad libitum smoking by menstrual phase. Human Psychopharmacology 2009, 24:503-506.
2. Allen S.S., Bade T., Center B., Finstad D., Hatsukami D. Menstrual phase effects on smoking relapse. Addiction 2008, 103:809-821.
3. Allen S.S., Hatsukami D., Christianson D., Brown S. Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle. Nicotine & Tobacco Research 2000, 2:231-241.
4. Allen S.S., Hatsukami D., Christianson D., Nelson D. Symptomatology and energy intake during the menstrual cycle in smoking women. Journal of Substance Abuse 1996, 8:303-319.
5. Allen S.S., Hatsukami D.K., Christianson D., Nelson D. Withdrawal and pre-menstrual symptomatology during the menstrual cycle in short-term smoking abstinence: Effects of menstrual cycle on smoking abstinence. Nicotine & Tobacco Research 1999, 1:129-142.
6. Anker J.J., Carroll M.E. The role of progestins in the behavioral effects of cocaine and other drugs of abuse: Human and animal research. Neuroscience and Biobehavioral Reviews 2010, 35(2):315-333.
7. Anker J.J., Holtz N.A., Zlebnik N., Carroll M.E. Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats. Psychopharmacology (Berlin) 2009, 203:63-72.
8. Anker J.J., Larson E.B., Gliddon L.A., Carroll M.E. Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats. Experimental and Clinical Psychopharmacology 2007, 15:472-480.
9. Battig K., Buzzi R., Nil R. Smoke yield of cigarettes and puffing behavior in men and women. Psychopharmacology 1982, 76:139-148.
10. Benowitz N.L., Lessov-Schlaggar C.N., Swan G.E., Jacob P. Female sex and oral contraceptive use accelerate nicotine metabolism. Clinical Pharmacology and Therapeutics 2006, 79:480-488.
11. Bertrand D., Valera S., Bertrand S., Ballivet M., Rungger D. Steroids inhibit nicotinic acetylcholine receptors. Neuroreport 1991, 2:277-280.
12. Brandon T.H., Tiffany S.T., Obremski K.M., Baker T.B. Postcessation cigarette use: The process of relapse. Addictive Behaviors 1990, 15:105-114.
13. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J., Finch C.E., Nilsen J. Progesterone receptors: Form and function in brain. Frontiers in Neuroendocrinology 2008, 29:313-339.
14. Bullock A.E., Clark A.L., Grady S.R., Robinson S.F., Slobe B.S., Marks M.J., Collins A.C. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. Journal of Neurochemistry 1997, 68:2412-2423.
15. Carpenter M., Upadhyaya H., LaRowe S., Saladin M., Brady K. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: A review. Nicotine and Tobacco Research 2006, 8:627-638.
16. Carpenter M.J., Saladin M.E., Leinbach A.S., Larowe S.D., Upadhyaya H.P. Menstrual phase effects on smoking cessation: A pilot feasibility study. Journal of Women's Health 2008, 17:293-301.
17. Carroll M.E., Anker J.J. Sex differences and ovarian hormones in animal models of drug dependence. Hormones and Behavior 2010, 58:44-56.
18. Cepeda-Benito A., Reynoso J.T., Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. Journal of Consulting and Clinical Psychology 2004, 72:712-722.
19. Chabbert Buffet N., Djakoure C., Maitre S.C., Bouchard P. Regulation of the human menstrual cycle. Frontiers in Neuroendocrinology 1998, 19:151-186.
20. Choi J.M., Romeo R.D., Brake W.G., Bethea C.L., Rosenwaks Z., McEwen B.S. Estradiol increases pre- and post-synaptic proteins in the CA1 region of the hippocampus in female rhesus macaques (Macaca mulatta). Endocrinology 2003, 144:4734-4738.
21. Colman G.J., Joyce T. Trends in smoking before, during, and after pregnancy in ten states. American Journal of Preventive Medicine 2003, 24:29-35.
22. Colzato L.S., Hertsig G., van den Wildenberg W.P., Hommel B. Estrogen modulates inhibitory control in healthy human females: Evidence from the stop-signal paradigm. Neuroscience 2010, 167:709-715.
23. Cunningham F., Leveno K., Bloom S., Hauth J., Gilstrap L., Wenstrom K. Williams obstetrics. Normal Labor and Delivery 2005, McGraw Hill Companies, New York. 22nd Ed.
24. Cyr M., Ghribi O., Di Paolo T. Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain. Journal of Neuroendocrinology 2000, 12:445-452.
25. Dar D.E., Zinder O. Short term effect of steroids on catecholamine secretion from bovine adrenal medulla chromaffin cells. Neuropharmacology 1997, 36:1783-1788.
26. DeBon M., Klesges R.C., Klesges L.M. Symptomatology across the menstrual cycle in smoking and nonsmoking women. Addictive Behaviors 1995, 20:335-343.
27. de Lignieres B. Oral micronized progesterone. Clinical Therapeutics 1999, 21:41-60. discussion 41-42.
28. DiClemente C.C., Dolan-Mullen P., Windsor R.A. The process of pregnancy smoking cessation: Implications for interventions. Tobacco Control 2000, 9(Suppl. 3):iii16-iii21.
29. DiFranza J.R., Savageau J.A., Rigotti N.A., Fletcher K., Ockene J.K., McNeill A.D., Wood C. Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study. Tobacco Control 2002, 11:228-235.
30. Dohler K.D., Wuttke W. Changes with age in levels of serum gonadotropins, prolactin and gonadal steroids in prepubertal male and female rats. Endocrinology 1975, 97:898-907.
31. Donny E.C., Caggiula A.R., Rowell P.P., Gharib M.A., Maldovan V., Booth S., McCallum S. Nicotine self-administration in rats: Estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology (Berlin) 2000, 151:392-405.
32. Dreher J.C., Schmidt P.J., Kohn P., Furman D., Rubinow D., Berman K.F. Menstrual cycle phase modulates reward-related neural function in women. Proceedings of the National Academy of Sciences, USA of the United States of America 2007, 104:2465-2470.
33. Eissenberg T., Adams C., Riggins E.C., Likness M. Smokers' sex and the effects of tobacco cigarettes: Subject-rated and physiological measures. Nicotine & Tobacco Research 1999, 1:317-324.
34. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31:659-674.
35. Evans S.M., Haney M., Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berlin) 2002, 159:397-406.
36. Fant R.V., Buchhalter A.R., Buchman A.C., Henningfield J.E. Pharmacotherapy for tobacco dependence. Handbook of Experimental Pharmacology 2009, 192:487-510.
37. Feltenstein M.W., Byrd E.A., Henderson A.R., See R.E. Attenuation of cocaine-seeking by progesterone treatment in female rats. Psychoneuroendocrinology 2009, 34:343-352.
38. Feltenstein M.W., See R.E. Plasma progesterone levels and cocaine-seeking in freely cycling female rats across the estrous cycle. Drug and Alcohol Dependence 2007, 18:18.
39. Franklin T.R., Allen S.S. Influence of menstrual cycle phase on smoking cessation treatment outcome: A hypothesis regarding the discordant findings in the literature. Addiction 2009, 104:1941-1942.
40. Franklin T.R., Ehrman R., Lynch K., Harper D., Sciortino N., O'Brien C., Childress A.R. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: A retrospective analysis. Journal of Women's Health 2008, 17:287-292.
41. Franklin T.R., Napier K., Ehrman R., Gariti P., O'Brien C.P., Childress A.R. Retrospective study: Influence of menstrual cycle on cue-induced cigarette craving. Nicotine & Tobacco Research 2004, 6:171-175.
42. Freeman E.W., Rickels K., Sondheimer S.J., Polansky M. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. Journal of the American Medical Association 1995, 274:51-57.
43. Freeman M.E. The neuroendocrine control of the ovarian cycle of the rat. The physiology of reproduction 1994, 613-658. Raven Press, New York. 2nd ed. E. Knobil, J. Neill (Eds.).
44. Frye C.A. Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacology, Biochemistry and Behavior 2007, 86:209-219.
45. Frye C.A., Walf A.A. Progesterone to ovariectomized mice enhances cognitive performance in the spontaneous alternation, object recognition, but not placement, water maze, and contextual and cued conditioned fear tasks. Neurobiology of Learning and Memory 2008, 90:171-177.
46. Frye C.A., Walf A.A. Progesterone enhances performance of aged mice in cortical or hippocampal tasks. Neuroscience Letters 2008, 437:116-120.
47. Gangitano D., Salas R., Teng Y., Perez E., De Biasi M. Progesterone modulation of alpha5 nAChR subunits influences anxiety-related behavior during estrus cycle. Genes, Brain, and Behavior 2009, 8:398-406.
48. Goodman L.S., Gilman A., Hardman J.G., Gilman A.G., Limbird L.E. Goodman & Gilman's the pharmacological basis of therapeutics 1996, McGraw-Hill Health Professions Division, New York. 9th ed.
49. Gron G., Friess E., Herpers M., Rupprecht R. Assessment of cognitive performance after progesterone administration in healthy male volunteers. Neuropsychobiology 1997, 35:147-151.
50. Harburger L.L., Pechenino A.S., Saadi A., Frick K.M. Post-training progesterone dose-dependently enhances object, but not spatial, memory consolidation. Behavioural Brain Research 2008, 194:174-180.
51. Hecht G.S., Spear N.E., Spear L.P. Changes in progressive ratio responding for intravenous cocaine throughout the reproductive process in female rats. Developmental Psychobiology 1999, 35:136-145.
52. Henderson V.W. Cognitive changes after menopause: Influence of estrogen. Clinical Obstetrics and Gynecology 2008, 51:618-626.
53. Henningfield J.E., Shiffman S., Ferguson S.G., Gritz E.R. Tobacco dependence and withdrawal: Science base, challenges and opportunities for pharmacotherapy. Pharmacology and Therapeutics 2009, 123:1-16.
54. Herzog A.G. Catamenial epilepsy: Definition, prevalence pathophysiology and treatment. Seizure 2008, 17:151-159.
55. Hofer I., Nil R., Wyss F., Battig K. The contributions of cigarette yield, consumption, inhalation and puffing behaviour to the prediction of smoke exposure. The Clinical Investigator 1992, 70:343-351.
56. Jackson L.R., Robinson T.E., Becker J.B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 2006, 31:129-138.
57. Kenford S.L., Fiore M.C., Jorenby D.E., Smith S.S., Wetter D., Baker T.B. Predicting smoking cessation. Who will quit with and without the nicotine patch. Journal of the American Medical Association 1994, 271:589-594.
58. Kerstetter K.A., Kantak K.M. Differential effects of self-administered cocaine in adolescent and adult rats on stimulus-reward learning. Psychopharmacology (Berlin) 2007, 194:403-411.
59. Klein L.C., Stine M.M., Vandenbergh D.J., Whetzel C.A., Kamens H.M. Sex differences in voluntary oral nicotine consumption by adolescent mice: A dose-response experiment. Pharmacology, Biochemistry and Behavior 2004, 78:13-25.
60. Knobil E., Neill J.D. Knobil and Neill's physiology of reproduction 2006, Elsevier, Boston. 3rd ed.
61. Ko M., Schulken E.D. Factors related to smoking cessation and relapse among pregnant smokers. American Journal of Health Behavior 1998, 22:83.
62. Larson E.B., Anker J.J., Gliddon L.A., Fons K.S., Carroll M.E. Effects of estrogen and progesterone on the escalation of cocaine self-administration in female rats during extended access. Experimental and Clinical Psychopharmacology 2007, 15:461-471.
63. Lesage M.G., Keyler D.E., Burroughs D., Pentel P.R. Effects of pregnancy on nicotine self-administration and nicotine pharmacokinetics in rats. Psychopharmacology 2007, 194:413-421.
64. Lynch W.J. Acquisition and maintenance of cocaine self-administration in adolescent rats: Effects of sex and gonadal hormones. Psychopharmacology 2008, 197:237-246.
65. Lynch W.J. Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats. Pharmacology, Biochemistry and Behavior 2009, 94:43-50.
66. Maki P.M. A systematic review of clinical trials of hormone therapy on cognitive function: Effects of age at initiation and progestin use. Annals of the New York Academy of Sciences 2005, 1052:182-197.
67. McAuley J.W., Kroboth F.J., Kroboth P.D. Oral administration of micronized progesterone: A review and more experience. Pharmacotherapy 1996, 16:453-457.
68. Meliska C.J., Bartke A., McGlacken G., Jensen R.A. Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice. Pharmacology, Biochemistry and Behavior 1995, 50:619-626.
69. Mello N.K. Hormones, nicotine, and cocaine: Clinical studies. Hormones and Behavior 2010, 58:57-71.
70. Mello N.K., Mendelson J.H. Cocaine's effects on neuroendocrine systems: Clinical and preclinical studies. Pharmacology, Biochemistry and Behavior 1997, 57:571-599.
71. Mello N.K., Mendelson J.H., Teoh S.K. Neuroendocrine consequences of alcohol abuse in women. Annals of the New York Academy of Sciences 1989, 562:211-240.
72. Mello N.K., Mendelson J.H., Palmieri S.L. Cigarette smoking by women: Interactions with alcohol use. Psychopharmacology 1987, 93:8-15.
73. Mullen P.D., Richardson M.A., Quinn V.P., Ershoff D.H. Postpartum return to smoking: Who is at risk and when. American Journal of Health Promotion 1997, 11:323-330.
74. Nilsen J., Brinton R.D. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:10506-10511.
75. O'Hara P., Portser S.A., Anderson B.P. The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addictive Behaviors 1989, 14:595-600.
76. Pazol K., Northcutt K.V., Patisaul H.B., Wallen K., Wilson M.E. Progesterone and medroxyprogesterone acetate differentially regulate alpha4 subunit expression of GABA(A) receptors in the CA1 hippocampus of female rats. Physiology and Behavior 2009, 97:58-61.
77. Pearson Murphy B.E., Allison C.M. Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum. Journal of Steroid Biochemistry and Molecular Biology 2000, 74:137-142.
78. Pepe G.J., Rothchild I. A comparative study of serum progesterone levels in pregnancy and in various types of pseudopregnancy in the rat. Endocrinology 1974, 95:275-279.
79. Perkins K.A. Smoking cessation in women. Special considerations. CNS Drugs 2001, 15:391-411.
80. Phillips S.M., Sherwin B.B. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 1992, 17:497-506.
81. Pierce J.P., Gilpin E. How long will today's new adolescent smoker be addicted to cigarettes?. American Journal of Public Health 1996, 86:253-256.
82. Pomerleau C.S., Cole P.A., Lumley M.A., Marks J.L., Pomerleau O.F. Effects of menstrual phase on nicotine, alcohol, and caffeine intake in smokers. Journal of Substance Abuse 1994, 6:227-234.
83. Pomerleau C.S., Garcia A.W., Pomerleau O.F., Cameron O.G. The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: A preliminary report. Psychoneuroendocrinology 1992, 17:627-638.
84. Pomerleau C.S., Teuscher F., Goeters S., Pomerleau O.F. Effects of nicotine abstinence and menstrual phase on task performance. Addictive Behaviors 1994, 19:357-362.
85. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association 2003, 289:2663-2672.
86. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., Shumaker S.A. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. Journal of Clinical Endocrinology and Metabolism 2006, 91:1802-1810.
87. Ridenour T.A., Lanza S.T., Donny E.C., Clark D.B. Different lengths of times for progressions in adolescent substance involvement. Addictive Behaviors 2006, 31:962-983.
88. Roberts D.C., Bennett S.A., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 1989, 98:408-411.
89. Romieu P., Martin-Fardon R., Bowen W.D., Maurice T. Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward. Journal of Neuroscience 2003, 23:3572-3576.
90. Rosenblatt J.S., Mayer A.D., Giordano A.L. Hormonal basis during pregnancy for the onset of maternal behavior in the rat. Psychoneuroendocrinology 1988, 13:29-46.
91. Russo S.J., Festa E.D., Fabian S.J., Gazi F.M., Kraish M., Jenab S., Quiñones-Jenab V. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 2003, 120:523-533.
92. Substance Abuse and Mental Health Services Administration 2008, SAMHSA, Results from the 2007 National Survey on Drug Use and Health: National findings. Office of Applied Studies. Rockville, MD.
93. Scharf D., Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR. Addiction 2004, 99:1462-1469.
94. Schussler P., Kluge M., Yassouridis A., Dresler M., Held K., Zihl J., Steiger A. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology 2008, 33:1124-1131.
95. Schweizer E., Case W.G., Garcia-Espana F., Greenblatt D.J., Rickels K. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: Effects on withdrawal severity and taper outcome. Psychopharmacology (Berlin) 1995, 117:424-429.
96. Simon J.A. Micronized progesterone: Vaginal and oral uses. Clinical Obstetrics & Gynecology 1995, 38:902-914.
97. Smith S.S. Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells. Neuroscience 1991, 42:309-320.
98. Smith S.S., Aoki C., Shen H. Puberty, steroids and GABA(A) receptor plasticity. Psychoneuroendocrinology 2009, 34(Suppl. 1):S91-S103.
99. Smith S.S., Shen H., Gong Q.H., Zhou X. Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits. Pharmacology and Therapeutics 2007, 116:58-76.
100. Snively T.A., Ahijevych K.L., Bernhard L.A., Mary Ellen W. Smoking behavior, dysphoric states and the menstrual cycle: Results from single smoking sessions and the natural environment. Psychoneuroendocrinology 2000, 25:677-691.
101. Sofuoglu M., Babb D.A., Hatsukami D.K. Progesterone treatment during the early follicular phase of the menstrual cycle: Effects on smoking behavior in women. Pharmacology, Biochemistry & Behavior 2001, 69:299-304.
102. Sofuoglu M., Babb D.A., Hatsukami D.K. Effects of progesterone treatment on smoked cocaine response in women. Pharmacology, Biochemistry and Behavior 2002, 72:431-435.
103. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P.R., Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Experimental and Clinical Psychopharmacology 1999, 7:274-283.
104. Sofuoglu M., Mitchell E., Kosten T.R. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacology, Biochemistry and Behavior 2004, 78:699-705.
105. Sofuoglu M., Mitchell E., Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Human Psychopharmacology 2009, 24:559-564.
106. Sofuoglu M., Mitchell E., Mooney M., Sofuoglu M., Mitchell E., Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Human Psychopharmacology 2009, 24:559-564.
107. Sofuoglu, M., Mouratidis, M., & Mooney, M. (in press). Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology.
108. Sofuoglu M., Poling J., Gonzalez G., Gonsai K., Oliveto A., Kosten T.R. Progesterone effects on cocaine use in male cocaine users maintained on methadone: A randomized, double-blind, pilot study. Experimental and Clinical Psychopharmacology 2007, 15:453-460.
109. Solis-Ortiz S., Corsi-Cabrera M. Sustained attention is favored by progesterone during early luteal phase and visuo-spatial memory by estrogens during ovulatory phase in young women. Psychoneuroendocrinology 2008, 33:989-998.
110. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Research Rev 2008, 57:386-397.
111. Steinberg J.L., Cherek D.R. Menstrual cycle and cigarette smoking behavior. Addictive Behaviors 1989, 14:173-179.
112. Thorner E.D., Jaszyna-Gasior M., Epstein D.H., Moolchan E.T. Progression to daily smoking: Is there a gender difference among cessation treatment seekers?. Substance Use and Misuse 2007, 42:829-835.
113. Tong V.T., England L.J., Dietz P.M., Asare L.A. Smoking patterns and use of cessation interventions during pregnancy. American Journal of Preventive Medicine 2008, 35:327-333.
114. Valera S., Ballivet M., Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proceedings of the National Academy of Sciences, USA 1992, 89:9949-9953.
115. van Wingen G., van Broekhoven F., Verkes R.J., Petersson K.M., Backstrom T., Buitelaar J., Fernández G. How progesterone impairs memory for biologically salient stimuli in healthy young women. Journal of Neuroscience 2007, 27:11416-11423.
116. Woolley C.S., McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. Journal of Comparative Neurology 1993, 336:293-306.
117. Zeman M.V., Hiraki L., Sellers E.M. Gender differences in tobacco smoking: Higher relative exposure to smoke than nicotine in women. Journal of Womens Health Gender Based Medicine 2002, 11:147-153.
118. Zumoff B., Miller L., Levin J., Levit C.D., Miller E.H., Heinz U., Rosenfeld R.S. Follicular-phase serum progesterone levels of nonsmoking women do not differ from the levels of nonsmoking men. Steroids 1990, 55(12):557-559.